These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 28756635)
1. Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive pulmonary disease? Telo S; Kırkıl G; Kuluöztürk M; Balin M; Deveci F Clin Respir J; 2018 Apr; 12(4):1433-1438. PubMed ID: 28756635 [TBL] [Abstract][Full Text] [Related]
2. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD. Aydin M; Altintas N; Cem Mutlu L; Bilir B; Oran M; Tülübaş F; Topçu B; Tayfur İ; Küçükyalçin V; Kaplan G; Gürel A Clin Respir J; 2017 May; 11(3):318-327. PubMed ID: 26076870 [TBL] [Abstract][Full Text] [Related]
3. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826 [TBL] [Abstract][Full Text] [Related]
4. Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD. Zinellu A; Fois AG; Sotgia S; Sotgiu E; Zinellu E; Bifulco F; Mangoni AA; Pirina P; Carru C PLoS One; 2016; 11(8):e0160237. PubMed ID: 27479314 [TBL] [Abstract][Full Text] [Related]
5. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker. Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T COPD; 2016; 13(2):139-45. PubMed ID: 26514682 [TBL] [Abstract][Full Text] [Related]
6. Cardiopulmonary exercise test and PaO Skjørten I; Hilde JM; Melsom MN; Hisdal J; Hansteen V; Steine K; Humerfelt S Int J Chron Obstruct Pulmon Dis; 2018; 13():91-100. PubMed ID: 29339921 [TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension. Skoro-Sajer N; Mittermayer F; Panzenboeck A; Bonderman D; Sadushi R; Hitsch R; Jakowitsch J; Klepetko W; Kneussl MP; Wolzt M; Lang IM Am J Respir Crit Care Med; 2007 Dec; 176(11):1154-60. PubMed ID: 17872491 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation. Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R Respiration; 2016; 91(1):9-17. PubMed ID: 26492415 [TBL] [Abstract][Full Text] [Related]
9. Positive correlation of airway resistance and serum asymmetric dimethylarginine level in COPD patients with systemic markers of low-grade inflammation. Tajti G; Gesztelyi R; Pak K; Papp C; Keki S; Szilasi ME; Mikaczo A; Fodor A; Szilasi M; Zsuga J Int J Chron Obstruct Pulmon Dis; 2017; 12():873-884. PubMed ID: 28352168 [TBL] [Abstract][Full Text] [Related]
10. Role of vasoactive intestinal peptide in chronic obstructive pulmonary disease with pulmonary hypertension. Lacedonia D; Valerio G; Palladino GP; Carpagnano GE; Correale M; Di Biase M; Foschino Barbaro MP Rejuvenation Res; 2014 Feb; 17(1):33-9. PubMed ID: 24228853 [TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and nitric oxide signaling related biomarkers in patients with pulmonary hypertension: a case control study. Zhang S; Yang T; Xu X; Wang M; Zhong L; Yang Y; Zhai Z; Xiao F; Wang C BMC Pulm Med; 2015 May; 15():50. PubMed ID: 25934483 [TBL] [Abstract][Full Text] [Related]
12. Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD. Urban MH; Eickhoff P; Funk GC; Burghuber OC; Wolzt M; Valipour A Int J Chron Obstruct Pulmon Dis; 2017; 12():169-176. PubMed ID: 28115840 [TBL] [Abstract][Full Text] [Related]
13. Systemic inflammation in patients with COPD and pulmonary hypertension. Joppa P; Petrasova D; Stancak B; Tkacova R Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829 [TBL] [Abstract][Full Text] [Related]
14. Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension. Henrohn D; Sandqvist A; Egeröd H; Hedeland M; Wernroth L; Bondesson U; Wikström G Vascul Pharmacol; 2015 Oct; 73():71-7. PubMed ID: 25934511 [TBL] [Abstract][Full Text] [Related]
15. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity. Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647 [TBL] [Abstract][Full Text] [Related]
17. Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Higham MA; Dawson D; Joshi J; Nihoyannopoulos P; Morrell NW Eur Respir J; 2001 Mar; 17(3):350-5. PubMed ID: 11405510 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD. Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734 [TBL] [Abstract][Full Text] [Related]
19. Echocardiographic Evaluation of the Relationship Between inflammatory factors (IL6, TNFα, hs-CRP) and Secondary Pulmonary Hypertension in patients with COPD. A Cross sectional study. Ansarin K; Rashidi F; Namdar H; Ghaffari M; Sharifi A Pneumologia; 2015; 64(3):31-5. PubMed ID: 26738368 [TBL] [Abstract][Full Text] [Related]